Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...

It was manufactured by a well-known pharmaceutical company and may be used to treat a specific group of patients managing ...

A Pennsylvania-based pharmaceutical firm and the FDA issued a recall of an injectable blood pressure medicine after a customer noticed "a visible black particulate matter" in a vial. Dr. Bernard Ashby ...

An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.

Provepharm is recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL at the hospital/institution ...

The FDA says administering a drug containing particulate matter may cause local irritation or swelling. If the particulates enter blood vessels, it can travel to various organs and potentially ...

Little dark things shouldn’t be in vials of a drug, which is why one lot of an injection drug used to deal with low blood pressure under anesthesia got ... As the company’s FDA-posted recall notice ...

It's not the only blood pressure medication recall to happen in recent months, but the FDA's concern appears to follow a common theme.

We had no shortage of blood pressure medication recalls in 2018, with multiple companies issuing warnings over drug impurities that could cause cancer. It looks like that trend will continue in ...

The company initiated the recall of the blood pressure treatment after a pharmacy ... according to a Jan. 24 news release from the FDA. In addition, if the particles enter the bloodstream, they ...

A blood pressure medication has been recalled from suppliers due to possible “microbial contamination”. Amlodipine is a ...